{
 "generic_name": "Lorlatinib Tablet",
 "slug": "lorlatinib-tablet",
 "brand_names": [
  "Lorbrena"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "06/15/2026",
 "first_posted": "06/15/2026",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Pfizer Inc.",
   "package_ndc": "0069-0227-03",
   "presentation": "Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Supply expected to exhaust 6/30/2026; NDC 0069-0227-01 25 mg; 30 tablets bottle with a child-resistant closure will continue to be manufactured; Discontinuation of the manufacture of this presentation"
  }
 ],
 "changes": []
}